Inhibition of glycoprotein biosynthesis in the pathogenic bacterium Helicobacter pylori by masked carbohydrate phosphonates

Key Points

• Glycoprotein biosynthesis inhibition has been shown in Helicobacter pylori with a phosphonate analogue.
• The analogue demonstrated significant effects by utilizing metabolic oligosaccharide engineering.
• Observational analysis suggests that this approach could lead to new therapeutic targets in infectious diseases.
• Further investigation into metabolism may provide insights for future treatments against Helicobacter pylori.

Abstract